# FDA Warning Letter: EyePoint Pharmaceuticals, Inc.
> 2024-08-27 · Office of Pharmaceutical Quality Operations Division I · `2727c21ca7e7efb1`
## Letter
- **Company:** EyePoint Pharmaceuticals, Inc.
- **Posted Date:** 2024-08-27
- **Letter Issue Date:** 2024-07-12
- **Issuing Office:** Office of Pharmaceutical Quality Operations Division I
## Subject
CGMP/Drugs/Adulterated
---
*Source: [FDA Warning Letters](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters) · AI Analytics · CC0 1.0*